- Home
- Services
- Regulatory Consulting
- EU MDR IVDR Consulting Services
EU MDR / IVDR Consulting and CE Markingfor Medical Device Manufacturers
From classification to your Notified Body certificate. NexorTest gives manufacturers everything under one roof for EU MDR and IVDR technical documentation, clinical and performance evaluation, testing, and Notified Body approval, so you reach all 30 EU and EEA markets with a plan your investors can trust.
Regulations (EU) 2017/745 and 2017/746
now need a Notified Body under IVDR, compared with about 8% under the old directive
First four modules mandatory since 28 May 2026
Documentation, testing, clinical evidence and NB approval
What Is CE Marking Under EU MDR and IVDR?
CE marking is the manufacturer’s declaration that a medical device or in vitro diagnostic (IVD) meets EU law, allowing it to be sold in all EU member states plus Iceland, Liechtenstein and Norway. Medical devices fall under the EU Medical Device Regulation (MDR) 2017/745, and IVDs under the In Vitro Diagnostic Regulation (IVDR) 2017/746. Except for the lowest-risk classes, a Notified Body must audit your quality system and review your technical documentation before you can affix the CE mark.
What manufacturers need to know first
- New devices go straight to MDR or IVDR. The transition extensions to 2027-2029 apply only to legacy devices certified under the old directives, not to new products.
- Notified Body capacity is limited. Around 50 bodies are designated under MDR and fewer than 20 under IVDR (Commission survey, February 2026). Book early.
- Clinical evidence is the hardest part. Equivalence to competitors’ devices is much harder to claim under MDR, so plan your clinical data from day one.
- Non-EU manufacturers need an EU Authorised Representative and an importer before placing devices on the market.
CE marking vs FDA 510(k)
The FDA 510(k) compares your device to a predicate. CE marking under MDR and IVDR asks you to prove conformity with the General Safety and Performance Requirements (GSPRs) in Annex I, with your own clinical or performance evidence. Most manufacturers target both markets. We build one evidence base that serves both. See our US FDA 510(k) consulting.
EU MDR vs IVDR: Which Regulation Applies to Your Product?
If your product examines specimens taken from the human body, such as blood, urine, tissue or saliva, to provide diagnostic information, it is an IVD under the IVDR. Instruments, software, and materials intended for medical purposes such as diagnosis, prevention, treatment, anatomical modification, or in vitro examination, provided its principal action is not pharmacological, immunological, or metabolic with medical purpose. Software that analyses IVD data, such as a genomic interpretation algorithm, is regulated under the IVDR.
| EU MDR (2017/745) | EU IVDR (2017/746) | |
|---|---|---|
| Covers | Medical devices, active implants, medical software, some non-medical aesthetic products (Annex XVI) | In vitro diagnostics: reagents, analysers, self-tests, companion diagnostics, IVD software |
| Risk classes | I (incl. Is, Im, Ir), IIa, IIb, III | A (incl. A sterile), B, C, D |
| Classification rules | 22 rules, Annex VIII | 7 rules, Annex VIII |
| Evidence | Clinical evaluation (Art. 61, Annex XIV), clinical investigations to ISO 14155 | Performance evaluation (Art. 56, Annex XIII): scientific validity, analytical and clinical performance |
| Key reports | CEP, CER, PMCF plan and report, PSUR, SSCP | PEP, PER, PMPF plan and report, PSUR, SSP |
| Notified Body needed | All classes except Class I (non-sterile, non-measuring, non-reusable surgical) | All classes except Class A non-sterile |
| Extra scrutiny | Clinical evaluation consultation by expert panels for certain Class III and IIb devices | EU reference laboratory testing and expert panel review for Class D |
More detail: EU MDR compliance services · EU IVDR compliance services
EU MDR and IVDR Device Classification for Manufacturers
Your risk class decides whether you can self-declare conformity or need a Notified Body, how much clinical or performance evidence you need, and how long CE marking takes. Classify early, using MDR Annex VIII (22 rules) or IVDR Annex VIII (7 rules) and the Commission’s MDCG guidance. A wrong classification is one of the most expensive mistakes a manufacturer can make.
| MDR class | Examples | Notified Body | Typical route |
|---|---|---|---|
| Class I | Non-sterile dressings, walking aids, examination gloves | No | Self-declaration (Annex II & III technical documentation) |
| Class Is / Im / Ir | Sterile, measuring function, or reusable surgical instruments | Limited to the sterile, measuring or reprocessing aspects | Annex IX or XI (limited scope) |
| Class IIa | Hearing aids, diagnostic ultrasound, much clinical software (Rule 11) | Yes | Annex IX QMS audit + technical documentation sampling |
| Class IIb | Ventilators, infusion pumps, X-ray systems | Yes | Annex IX. Implantable IIb devices are reviewed device by device |
| Class III | Heart valves, drug-eluting stents, breast implants | Yes | Annex IX full, plus clinical evaluation consultation for implantables |
| IVDR class | Examples | Notified Body | Typical route |
|---|---|---|---|
| Class A | Lab instruments, buffers, specimen receptacles | No (yes if sterile) | Self-declaration |
| Class B | General clinical chemistry, pregnancy and fertility self-tests | Yes | Annex IX QMS + technical documentation sampling |
| Class C | Cancer markers, companion diagnostics, genetic tests, most self-tests | Yes | Annex IX, with technical documentation reviewed per generic device group |
| Class D | HIV, hepatitis and blood-group screening, life-threatening transmissible agents | Yes | Annex IX per device, plus EU reference laboratory testing and expert panel |
CE Marking Support Designed Around Manufacturer Realities
Manufacturers rarely fail CE marking on safety. They lose a year to a Notified Body queue they joined too late, a clinical strategy built on equivalence that doesn’t hold, or a technical file the Notified Body sends back in rounds of questions. We plan around these risks from the first meeting.
"Our runway won't survive an 18-month NB review."
Notified Body strategy from week one
We shortlist Notified Bodies with your scope and capacity, get quotes, and help you sign early. We then build documentation in parallel so you are ready when your audit slot arrives.
"We can't claim equivalence to a competitor's device."
Clinical evidence you can actually generate
A clinical evaluation plan built on literature, your own bench and usability data, and a right-sized clinical investigation or PMCF study where needed. No equivalence claims that a Notified Body will reject.
"We have no regulatory or quality team."
Outsourced RA/QA and PRRC
Under MDR and IVDR Article 15, micro and small enterprises may have a Person Responsible for Regulatory Compliance (PRRC) permanently at their disposal instead of employing one. We can fill that role and run your QMS until you hire.
"We're a US, Indian or UK company."
EU Authorised Representative and EUDAMED
EU Authorised Representative coordination, Single Registration Number (SRN), Basic UDI-DI registration and importer set-up, so a non-EU manufacturer can legally place devices on the EU market.
"Five vendors, five timelines."
Testing and regulatory under one roof
Our labs run EMC, environmental, cybersecurity and usability testing, and we coordinate biocompatibility, electrical safety and IVD analytical studies. Every test report is written to map straight to the GSPR checklist.
"Investors want an EU and US plan."
One dossier, multiple markets
A single evidence base designed for CE marking, FDA 510(k), UKCA, CDSCO and MDSAP markets, with a dated, budgeted roadmap your board can track.
Our EU MDR and IVDR CE Marking Services
Use the full end-to-end service or only the modules you need. Every module produces documentation in the structure Notified Bodies expect.
Regulatory strategy & classification
- Qualification as a device or IVD
- Classification rationale (MDR or IVDR Annex VIII)
- Conformity assessment route and Notified Body shortlist
- CE roadmap with budget and milestones
ISO 13485 quality system
- Lean QMS sized for manufacturers, aligned with MDR/IVDR Article 10
- Design controls, supplier control, CAPA
- Internal audit and Notified Body audit preparation
- See our ISO 13485 consulting
Technical documentation (Annex II & III)
- Device description, variants and intended purpose
- GSPR checklist with evidence mapping
- Risk management file (EN ISO 14971)
- Labelling, IFU and symbols (EN ISO 15223-1, EN ISO 20417)
Clinical evaluation
- Clinical evaluation plan and report (CEP and CER, MEDDEV 2.7/1 rev 4 method)
- Systematic literature review
- Clinical investigation strategy (ISO 14155)
- PMCF plan and evaluation report
Performance evaluation
- Performance evaluation plan and report (PEP and PER)
- Scientific validity report
- Analytical and clinical performance study design (ISO 20916)
- PMPF plan and report
Verification & validation testing
- Test plan mapped to harmonised standards and GSPRs
- EMC, environmental, electrical safety, usability and cybersecurity testing
- Biocompatibility, sterilisation and shelf-life coordination
- IVD analytical performance and stability studies
Notified Body submission & audits
- Application and pre-application meetings
- Technical documentation submission
- Responses to NB questions and non-conformities
- Stage 1 and 2 QMS audit support
EUDAMED, UDI & Authorised Representative
- Actor registration and SRN
- Basic UDI-DI and UDI-DI registration
- EU Authorised Representative and importer set-up
- Declaration of Conformity and CE affixing
PMS, vigilance & surveillance audits
- PMS plan, PMS report or PSUR
- SSCP (MDR) or SSP (IVDR) where required
- Vigilance and field safety corrective actions
- Annual surveillance audit support
Testing Required for EU MDR and IVDR Approval
To meet the GSPRs, most devices are tested against harmonised European standards, which give a presumption of conformity, or other state-of-the-art standards. Typical MDR testing covers electrical safety (EN 60601-1), EMC (EN 60601-1-2), biocompatibility (EN ISO 10993), software (EN 62304), usability (EN 62366-1), sterilisation and shelf life. IVDs add analytical performance, stability (EN ISO 23640) and, for instruments, EN 61010 safety and EN 61326 EMC.
| Test | Key standard | Applies to | GSPR (Annex I) | NexorTest |
|---|---|---|---|---|
| Electrical safety | EN 60601-1 (+ particular standards), EN 61010-1 / 61010-2-101 for IVD instruments | MDR & IVDR | Ch. II (electrical and mechanical) | Test & manage |
| EMC / EMI | EN 60601-1-2, EN 61326-2-6 (IVD) | MDR & IVDR | Ch. II (environment and EMC) | In-house lab |
| Environmental, transport & packaging | EN 60068 series, ISO 11607, ASTM D4169 | MDR & IVDR | Ch. I & II | In-house lab |
| Software lifecycle | EN 62304, EN 82304-1 | MDR & IVDR | Software requirements in Ch. II | Full support |
| Cybersecurity | EN IEC 81001-5-1, MDCG 2019-16 | MDR & IVDR | Software and IT security requirements in Ch. II | Pen testing & SBOM |
| Usability / human factors | EN 62366-1 | MDR & IVDR (critical for self-tests) | Ch. I & II (use error, lay users) | In-house |
| Biocompatibility | EN ISO 10993 series | MDR (patient-contacting) | Ch. II (chemical and biological) | Coordinated with GLP labs |
| Sterilisation & shelf life | EN ISO 11135 / 11137 / 17665, ASTM F1980 | MDR & IVDR (sterile) | Ch. II (infection and contamination) | Coordinated |
| Analytical performance | CLSI EP series, EN ISO 20916 for performance studies | IVDR | Ch. II (performance characteristics) | Protocol & report |
| IVD stability | EN ISO 23640 | IVDR | Ch. I & II | Protocol & coordination |
Software or AI product? See SaMD and IEC 62304 consulting. Connected device? See cybersecurity testing, EMC/EMI testing and usability testing.
The CE Marking Process Under EU MDR and IVDR
To CE mark a medical device or IVD: confirm qualification and class; implement an ISO 13485 quality system; compile technical documentation and the GSPR checklist; complete testing and clinical or performance evaluation; apply to a Notified Body and pass the QMS audit and technical documentation review; then sign the EU Declaration of Conformity, register in EUDAMED and affix the CE mark.
Readiness assessment & classification
We confirm whether the product is a device or IVD, its class and conformity route, then give you a written gap list, Notified Body shortlist, timeline and budget.
Notified Body selection & application
We compare Notified Bodies on scope, capacity, lead time and fees, and help you sign the agreement early so the queue runs in parallel with your work.
Quality management system
We set up a lean ISO 13485 QMS that meets MDR/IVDR Article 10, including design controls, risk management, PMS and vigilance procedures.
Testing & verification
We run or coordinate the test programme against harmonised standards, with every report mapped to a GSPR.
Clinical or performance evaluation
We write the CEP and CER (MDR) or the PEP, scientific validity and PER (IVDR), and design any clinical investigation or performance study needed.
Technical documentation compilation
We assemble Annex II and III documentation, run an internal “mock Notified Body” review, and submit.
Notified Body audit & review
We support the Stage 1 and 2 QMS audits and answer every round of technical documentation questions until the certificate is issued.
Declaration, EUDAMED & CE mark
We prepare the EU Declaration of Conformity, complete actor and UDI registration in EUDAMED, set up your Authorised Representative and importer, and plan your PMS and surveillance audits.
EU MDR and IVDR Technical Documentation Checklist
MDR and IVDR technical documentation is defined in Annex II (pre-market) and Annex III (post-market surveillance). It must be clear, organised and searchable, and kept up to date for the life of the device, plus at least 10 years after the last device is placed on the market (15 years for MDR implantables).
Annex II: Technical documentation
- Device description, intended purpose, variants and accessories, Basic UDI-DI
- Labels and instructions for use in the required languages
- Design and manufacturing information, including sites and suppliers
- General Safety and Performance Requirements checklist
- Benefit-risk analysis and risk management file
- Product verification and validation: test reports, software V&V, biocompatibility, stability
- Clinical evaluation report (MDR) or performance evaluation report (IVDR)
Annex III: Post-market surveillance
- Post-market surveillance plan
- PMCF (MDR) or PMPF (IVDR) plan and evaluation report
- PMS report (Class I and Class A/B) or PSUR (higher classes)
- Summary of Safety and Clinical Performance (SSCP, MDR Class III and implantables) or Summary of Safety and Performance (SSP, IVDR Class C and D)
- Trend reporting and vigilance procedures
- EU Declaration of Conformity (Annex IV)
How Long Does CE Marking Take and What Does It Cost?
For manufacturers, CE marking under MDR typically takes 3-6 months for self-declared Class I devices and 12-24 months for Class IIa to III devices involving a Notified Body. Under IVDR, Class A takes a few months, while Class B to D usually takes 12–24 months. Costs come from Notified Body fees, testing, clinical or performance evidence, and consulting, and vary mainly by risk class and how much clinical data you need.
| Class | Typical timeline | Main cost drivers |
|---|---|---|
| MDR Class I / IVDR Class A (non-sterile) | 3-6 months | Technical documentation, testing, EUDAMED and Authorised Representative. No Notified Body fees |
| MDR Is / Im / Ir / IVDR A sterile | 6-12 months | Limited-scope Notified Body review, sterilisation or metrology validation |
| MDR Class IIa / IVDR Class B | 12-18 months | Notified Body QMS audit and documentation sampling, testing, clinical or performance evaluation |
| MDR Class IIb / IVDR Class C | 15-24 months | Deeper Notified Body review, larger clinical or performance evidence, possible clinical study |
| MDR Class III / IVDR Class D | 18-30 months | Clinical investigation or performance study, expert panel or EU reference laboratory, per-device review |
| Cost item | Notes |
|---|---|
| Notified Body fees | Application, QMS audits, technical documentation review and annual surveillance. Set by each Notified Body, so we get comparable quotes for you |
| Testing | Depends on technology. Scoped in the readiness assessment against the GSPRs |
| Clinical / performance evidence | Literature-based evaluation, or a clinical investigation or performance study if data gaps exist. Usually the largest variable cost |
| EU Authorised Representative and PRRC | Annual fee for non-EU manufacturers and for manufacturers without an in-house PRRC |
| NexorTest consulting | Fixed fee per phase, quoted after a free readiness assessment |
EU MDR and IVDR in 2026: Deadlines and Changes Manufacturers Should Know
| Topic | Status | What it means for a manufacturer |
|---|---|---|
| EUDAMED | Actor registration, UDI/device registration, Notified Body & certificates, and market surveillance modules mandatory since 28 May 2026 | You need an SRN and must register your devices in EUDAMED before placing them on the market |
| MDR legacy transition (Reg. 2023/607) | Legacy MDD/AIMDD devices: until 31 Dec 2027 (Class III, IIb implantable) or 31 Dec 2028 (other classes), if conditions are met | Does not apply to new devices. A new product must be certified under MDR |
| IVDR legacy transition (Reg. 2024/1860) | Legacy IVDD devices: Class D until 31 Dec 2027, Class C until 31 Dec 2028, Class B and A sterile until 31 Dec 2029 | Does not apply to new IVDs. Expect competition for IVDR Notified Body capacity |
| MDR/IVDR targeted revision | Commission proposal of December 2025 under negotiation in Parliament and Council | Proposes simplification, such as certificate validity and sampling. No change to current obligations until adopted |
| EU AI Act | High-risk obligations for AI in medical devices and IVDs apply from 2 August 2028 (amended by the 2026 Digital Omnibus) | AI manufacturers should design for AI Act requirements now, alongside MDR/IVDR |
Why Notified Bodies Send Back Manufacturer Technical Files and How We Prevent It
- Insufficient clinical evidence: equivalence claims without access to the equivalent device’s technical documentation.Fix: an evidence strategy built on your own data and PMCF.
- Weak GSPR checklist: requirements marked “applicable” without traceable evidence.Fix: each GSPR linked to a specific document, test report and standard edition.
- Inconsistent intended purpose: different wording across the IFU, CER, risk file and labels.Fix: one controlled intended-purpose statement used everywhere.
- Outdated standards: testing to superseded editions without a gap justification.Fix: a state-of-the-art standards list reviewed at every submission.
- PMS treated as an afterthought: generic PMS and PMCF plans.Fix: device-specific PMS with defined data sources and thresholds.
- Software and cybersecurity gaps: missing IEC 62304 evidence or a missing IT security risk assessment.Fix: software and cybersecurity files built with development.
Why Manufacturers Choose NexorTest for EU MDR and IVDR CE Marking
Design, testing and regulatory in one team
We help design the product for compliance, run the testing in our labs, and write the documentation, so there are no gaps between vendors and no re-testing surprises.
MDR and IVDR under one roof
Medical device, IVD, combination and software products, including IVD software and companion diagnostics that cross both regulations.
EU and US together
One evidence base for CE marking and FDA 510(k), plus UKCA, CDSCO and MDSAP markets, so you don’t build two dossiers.
Manufacturer-friendly commercials
Phased, fixed-fee engagements aligned to funding rounds, with a free readiness assessment before you commit.
Offices in Europe, the UK, the US, India and the UAE
EU-time-zone support with engineering capacity that keeps costs within a manufacturer budget.
Named senior lead
Every manufacturer engagement has a named senior regulatory lead who stays with you from assessment to certificate.
EU MDR and IVDR CE Marking FAQ's
How long does CE marking under EU MDR take?
Self-declared Class I devices typically take 3-6 months. Devices that need a Notified Body (Class Is/Im/Ir, IIa, IIb and III) commonly take 12-24 months from project start, with Class III often longer. Notified Body capacity and the strength of your clinical evidence are the biggest variables.
How long does IVDR certification take?
Class A non-sterile IVDs can be self-declared in a few months. Class B, C and D IVDs need a Notified Body and usually take 12–24 months, with Class D taking longest because of EU reference laboratory testing and expert panel review.
Does my manufacturer need a Notified Body?
Under MDR, only Class I devices that are non-sterile, have no measuring function and are not reusable surgical instruments can be self-declared. Under IVDR, only non-sterile Class A IVDs can be self-declared. All other devices and IVDs need a Notified Body certificate before CE marking.
Can a new device use the MDR or IVDR transition extensions?
No. The extended transition periods to 2027–2029 apply only to legacy devices already certified or declared under the old directives (MDD, AIMDD or IVDD) that meet the conditions in Regulations (EU) 2023/607 and 2024/1860. A new device must be certified under MDR or IVDR from the start.
Does a non-EU manufacturer need an EU Authorised Representative?
Yes. A manufacturer without a registered place of business in the EU must appoint an EU Authorised Representative under Article 11 of the MDR or IVDR, and needs an EU importer to place devices on the market. Both must be registered in EUDAMED.
Is EUDAMED registration mandatory?
Yes. Since 28 May 2026, the actor registration, UDI/device registration, Notified Body and certificates, and market surveillance modules of EUDAMED are mandatory. Manufacturers, Authorised Representatives and importers need a Single Registration Number (SRN), and devices must be registered with their Basic UDI-DI.
Is software a medical device under EU MDR?
Software intended by the manufacturer for a medical purpose, such as diagnosis, monitoring or treatment decisions, is a medical device under MDR, or an IVD under IVDR if it uses data from IVD tests. Under MDR Rule 11 most such software is Class IIa or higher and needs a Notified Body. MDCG 2019-11 explains how to qualify and classify software.
Can the same documentation be used for FDA 510(k) and CE marking?
Largely, yes. Testing to recognised standards, risk management to ISO 14971, software documentation to IEC 62304 and usability to IEC 62366-1 serve both. The main differences are the regulatory argument (predicate equivalence for FDA vs GSPRs and clinical evaluation for the EU), the EU’s post-market documentation, and labelling.
Find Out How Close You Are to CE Marking
Our free CE marking readiness assessment confirms MDR or IVDR, your class and conformity route, shortlists Notified Bodies, lists the testing and clinical evidence you need, and gives you a timeline and budget you can share with investors.